A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Subscribe to ...

A tRNA-derived RNA fragment elevated in acute myeloid leukemia promotes cell growth and survival by suppressing AGGF1 and is ...

Retail bulls discussed buying the dip and a potential buyout, while others also challenged survival estimates.

(Nasdaq:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today announced that ten patients with newly diagnosed acute myeloid leukemia (AML) ...

Panelists discuss how implementing oral regimens faces significant operational barriers including formulary restrictions, prior authorization requirements, insurance coverage differences between ...

Dr. Mahmoudjafari asks Dr. Murthy how he weighs frailty, comorbidities, and functional status when choosing initial treatment ...

A five-year National Cancer Institute grant will support efforts to identify biomarkers that predict response and relapse in ...

Austrian and Dutch forecasts point to potential GPS approval or registration in November and August 2027, respectively.

Acute myeloid leukemia (AML), an aggressive and often fatal blood cancer, has long resisted a class of drugs called proteasome inhibitors, which work well in multiple myeloma. A new study by ...

Acute myeloblastic leukemia (AML) is another name for acute myeloid leukemia. AML refers to a group of cancers of the blood and the bone marrow. AML, which medical experts also call acute myeloid ...

Newswise — Acute myeloid leukemia (AML), an aggressive and often fatal blood cancer, has long resisted a class of drugs called proteasome inhibitors, which work well in multiple myeloma. A new study ...